Sumathi Sivapalasingam

Sumathi Sivapalasingam

Directeur Technique/Scientifique/R&D chez UPSTREAM BIO, INC.
Health Technology
Consumer Services

Profil

Sumathi Sivapalasingam is Vice President & Head-Clinical Development at Upstream Bio, Inc. since 2023.
Former roles include Vice President-Translational Medicine at Excision BioTherapeutics, Inc. from 2021 to 2023, Senior Director-Early Clinical Development at Regeneron Pharmaceuticals, Inc. from 2012 to 2021, and Director at New York University School of Medicine.
Education includes undergraduate studies at Swarthmore College and a doctorate from Albert Einstein College of Medicine, Inc.

Postes actifs de Sumathi Sivapalasingam

SociétésPosteDébut
UPSTREAM BIO, INC. Directeur Technique/Scientifique/R&D 01/01/2023

Anciens postes connus de Sumathi Sivapalasingam

SociétésPosteFin
Corporate Officer/Principal 01/03/2023
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 01/06/2021
Directeur/Membre du Conseil -
Voir l'expérience en détail de Sumathi Sivapalasingam

Formation de Sumathi Sivapalasingam

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

21

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Sumathi Sivapalasingam
🔇